Package 68462-945-10

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2dead4d5-7696-4cf9-b8dc-5d10da310df3", "openfda": {"upc": ["0368462945643"], "unii": ["7VLR55452Z"], "rxcui": ["1670195"], "spl_set_id": ["bb38bc6a-99c7-4cda-b3f0-37f629d060cf"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (68462-945-10)  / 10 mL in 1 VIAL, SINGLE-DOSE (68462-945-64)", "package_ndc": "68462-945-10", "marketing_start_date": "20250528"}], "brand_name": "Fosphenytoin sodium", "product_id": "68462-945_2dead4d5-7696-4cf9-b8dc-5d10da310df3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-945", "generic_name": "Fosphenytoin sodium", "labeler_name": "GLENMARK PHARMACEUTICALS INC., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin sodium", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA214926", "marketing_category": "ANDA", "marketing_start_date": "20250528", "listing_expiration_date": "20271231"}